abstract |
The present invention provides novel activin IIB5 receptor polypeptides that can bind to and inhibit the activity of activin A, myostatin, or GDF-11. The invention also provides polynucleotides, vectors and host cells capable of producing the receptor polypeptide. Compositions and methods for treating muscle atrophy, metabolism and other disorders are also provided. |